Opus Genetics, Inc. (NASDAQ:IRD) is one of the best performing small cap stocks so far in 2026. On April 28, Citizens initiated coverage of Opus Genetics, Inc. (NASDAQ:IRD) with an Outperform rating, ...
Fintel reports that on March 16, 2026, Oppenheimer initiated coverage of Opus Genetics (NasdaqCM:IRD) with a Outperform recommendation. Analyst Price Forecast Suggests 56.70% Upside As of February 25, ...
Abstract: In response to the increasing complexity of urban wellness resource allocation, this paper proposes a hybrid computational framework that integrates Graph Convolutional Networks (GCNs) and ...
Detailed insurance coverage charts can establish an understanding of complex insurance programs. The charts can identify important issues, and convey key information to clients and non-insurance ...
UC Davis Ph.D. candidate Abigail Morris is studying how environmental factors influence the decisions individual monkeys make when they disperse from their family groups in the Amazon. (Courtesy photo ...
London-based Decagon Asset Management bought 137,732 shares of Chart Industries in the third quarter. The move increase dthe fund's reported U.S. equity exposure by $27.57 million. The stake is now ...
Hosted on MSN
Piper Sandler Initiates Coverage on Opus Genetics, Inc. (IRD) With “Overweight” Rating and $7 PT
Opus Genetics, Inc. (NASDAQ:IRD) is one of the 12 hot penny stocks to invest in right now. Ikonoklast Fotografie/Shutterstock.com On November 25, 2025, The Fly reported that Piper Sandler initiated ...
A new study has found that marijuana use could be damaging to a woman's reproductive system. Researchers tested human eggs and embryos for the first time from more than 1,050 participants and compared ...
Traditional Medicare will face greater use of prior authorizations under a pilot program by the Centers for Medicare & Medicaid Services, potentially eroding one area that enrollees like about their ...
An Illinois appellate court has ruled in favor of ISMIE Mutual Insurance Company in a closely watched professional liability coverage dispute involving a prenatal genetic testing lawsuit. The decision ...
On May 27, 1961, Heinrich Matthaei, a postdoc working with NIH scientist Marshal Nirenberg, placed synthetic polyuracil RNA into 20 test tubes to see what it would produce. Each tube contained ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results